{"corpus_id":22166340,"paper_sha":"d5fd5fd6ca635195b1ea95c206d67194143bebb2","doi":"10.1016/s0026-895x(25)09832-3","arxiv_id":null,"pmid":7969079,"pmcid":null,"mag_id":2418788097,"dblp_id":null,"acl_id":null,"title":"Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.","year":1994,"publication_date":"1994-11-01","venue":"Molecular Pharmacology","journal":{"name":"Molecular pharmacology","pages":"\n          909-14\n        ","volume":"46 5"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, U.S. Gov't, P.H.S."],"s2_fields_of_study":["Biology","Medicine"],"reference_count":0,"citation_count":46,"influential_citation_count":1,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Drug Resistance","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D004351"},{"d":"Gene Expression Regulation, Enzymologic","mj":false,"qs":[{"q":"physiology","mj":true,"ui":"Q000502"}],"ui":"D015971"},{"d":"Gene Expression Regulation, Neoplastic","mj":false,"qs":[{"q":"physiology","mj":true,"ui":"Q000502"}],"ui":"D015972"},{"d":"Glutamate-Cysteine Ligase","mj":false,"qs":[{"q":"biosynthesis","mj":true,"ui":"Q000096"}],"ui":"D005721"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Melphalan","mj":false,"qs":[{"q":"pharmacology","mj":true,"ui":"Q000494"}],"ui":"D008558"},{"d":"Prostatic Neoplasms","mj":false,"qs":[{"q":"enzymology","mj":true,"ui":"Q000201"}],"ui":"D011471"},{"d":"Transcription, Genetic","mj":false,"qs":[{"q":"physiology","mj":false,"ui":"Q000502"}],"ui":"D014158"},{"d":"Tumor Cells, Cultured","mj":false,"ui":"D014407"},{"d":"Up-Regulation","mj":false,"qs":[{"q":"physiology","mj":false,"ui":"Q000502"}],"ui":"D015854"}],"chemicals":[{"n":"Glutamate-Cysteine Ligase","ui":"D005721","reg":"EC 6.3.2.2"},{"n":"Melphalan","ui":"D008558","reg":"Q41OR9510P"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Tumor cell resistance to many chemotherapeutic agents, including alkylating agents, cisplatin, and doxorubicin, is frequently associated with increased intracellular levels of the nonprotein sulfhydryl glutathione (GSH). Recent evidence has demonstrated that increased GSH levels can be accompanied by an increase in the activity of gamma-glutamylcysteine synthetase (GCS), which catalyzes the rate-limiting step in de novo synthesis of GSH, and by an increase in the steady state level of mRNA for the catalytic subunit of GCS. Using melphalan-resistant DU 145/M4.5 human prostate carcinoma cells, which express elevated GSH levels, GCS enzyme activity, and GCS mRNA levels, we sought to determine the mechanism(s) responsible for the increased GCS mRNA expression. As determined by Northern analyses and RNase protection assays, the steady state level of GCS message in the resistant cells was increased 10-20-fold, in comparison with the drug-sensitive parent DU 145 cells. No significant difference in gene copy number or evidence of rearrangement was detected in the resistant cell line by Southern analyses. The GCS-specific mRNA isolated from the resistant cells was less stable than that isolated from the drug-sensitive cells (half-lives of 6 hr and 9 hr, respectively), indicating that this difference does not contribute to the increased steady state levels in the resistant cells. Nuclear run-on experiments revealed that the GCS transcription rate in the DU 145/M4.5 cells was increased approximately 12-fold, in comparison with that detected in the DU 145 cells. This difference in transcription rate was comparable in magnitude to the difference in steady state mRNA levels detectable in the two cell populations. Similar correlations between steady state GCS mRNA levels and transcription rates were also observed in other DU 145 lines expressing intermediate degrees of resistance to melphalan and correspondingly intermediate GCS mRNA elevations. These data suggest that GCS expression is transcriptionally regulated in these melphalan-resistant tumor cells.","claims":[{"public_id":"cl_8d2a1f1f1a75bb8a58f6423e77ad8aa9","status":"active","text":"GCS expression in these melphalan-resistant tumor cells is regulated at the transcriptional level.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_8d2a1f1f1a75bb8a58f6423e77ad8aa9"},{"public_id":"cl_47fa0f36c8a737dbff95cfe99aed5f19","status":"active","text":"GCS mRNA in the resistant cells is less stable than in the drug-sensitive cells, with half-lives of 6 hr versus 9 hr.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_47fa0f36c8a737dbff95cfe99aed5f19"},{"public_id":"cl_90ee879e3cf4bbe832ea5ca290ea04a9","status":"active","text":"GCS steady-state mRNA levels are increased 10-20-fold in melphalan-resistant DU 145/M4.5 cells compared with the drug-sensitive DU 145 parent line.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_90ee879e3cf4bbe832ea5ca290ea04a9"},{"public_id":"cl_3b700b51f7bad0c21470d9ae270ab588","status":"active","text":"GCS transcription rate is increased approximately 12-fold in DU 145/M4.5 cells relative to DU 145 cells, matching the magnitude of the steady-state mRNA increase.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_3b700b51f7bad0c21470d9ae270ab588"},{"public_id":"cl_bf8ac75072a065355cb063bae01e0e17","status":"active","text":"No significant change in gene copy number or evidence of rearrangement is detected in the resistant cell line.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_bf8ac75072a065355cb063bae01e0e17"}],"concepts":[{"public_id":"co_038502c7631891af74a0686bb14d13ba","status":"active","name":"DU 145 cells","description":"The drug-sensitive parent human prostate carcinoma cell line used as a comparison control.","types":["cell line"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_038502c7631891af74a0686bb14d13ba"},{"public_id":"co_12911f2525359c866493acc7f283b17b","status":"active","name":"gene copy number","description":"The number of copies of a gene present in the genome.","types":["genomic feature"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_12911f2525359c866493acc7f283b17b"},{"public_id":"co_26ab2a845ae61920caead5abfcc1d52a","status":"active","name":"glutathione","description":"A nonprotein sulfhydryl compound involved in cellular redox balance and drug resistance.","types":["molecule"],"aliases":["GSH"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_26ab2a845ae61920caead5abfcc1d52a"},{"public_id":"co_3b060362b327d57faf1be08a39e8b019","status":"active","name":"melphalan-resistant DU 145/M4.5 human prostate carcinoma cells","description":"A melphalan-resistant human prostate carcinoma cell line used to study altered GCS expression.","types":["cell line"],"aliases":["DU 145/M4.5 cells"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3b060362b327d57faf1be08a39e8b019"},{"public_id":"co_5d9a90141d54baa19132b21101f38370","status":"active","name":"melphalan","description":"An alkylating chemotherapeutic agent used here as the selective drug.","types":["drug"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5d9a90141d54baa19132b21101f38370"},{"public_id":"co_6b8a10b2ab1e6777458c8918f9b2a2a6","status":"active","name":"nuclear run-on experiments","description":"Assays that measure the rate of ongoing transcription in isolated nuclei.","types":["assay"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6b8a10b2ab1e6777458c8918f9b2a2a6"},{"public_id":"co_7bf4b6dc5c37ea1975abbb9f856750cd","status":"active","name":"Southern analyses","description":"DNA hybridization assays used to assess gene copy number and structural changes.","types":["assay"],"aliases":["Southern blot"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7bf4b6dc5c37ea1975abbb9f856750cd"},{"public_id":"co_852bd4123fdf237ab22aa7719f9f3566","status":"active","name":"rearrangement","description":"Structural alteration of a gene or genomic region detectable by Southern analysis.","types":["genomic alteration"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_852bd4123fdf237ab22aa7719f9f3566"},{"public_id":"co_9a6a6d7d6db58d5b6cabc0e23a98a9a1","status":"active","name":"RNase protection assays","description":"RNA assays used to detect and quantify specific transcript levels.","types":["assay"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9a6a6d7d6db58d5b6cabc0e23a98a9a1"},{"public_id":"co_bbe318c44c28f918b7063feb9123b608","status":"active","name":"Northern analyses","description":"Hybridization-based assays used to measure RNA abundance.","types":["assay"],"aliases":["Northern blot"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_bbe318c44c28f918b7063feb9123b608"},{"public_id":"co_da9dc6291d54aa761b18b7e18b890e9b","status":"active","name":"gamma-glutamylcysteine synthetase","description":"The enzyme that catalyzes the rate-limiting step in de novo glutathione synthesis.","types":["enzyme","gene"],"aliases":["GCS","gamma-glutamylcysteine synthetase gene"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_da9dc6291d54aa761b18b7e18b890e9b"},{"public_id":"co_ef773d28b1b2d0eb7728067d939af1f7","status":"active","name":"steady-state mRNA level","description":"The abundance of an mRNA transcript at equilibrium between synthesis and degradation.","types":["measurement"],"aliases":["steady state level of mRNA"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ef773d28b1b2d0eb7728067d939af1f7"}],"external_ids":{"DOI":"10.1016/s0026-895x(25)09832-3","ArXiv":null,"PubMed":7969079,"PubMedCentral":null,"MAG":2418788097,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/22166340","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"unknown","references_indexed":false,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":630612,"paper_uid":"f0028e3f-4fe7-4b56-ad8f-e1473f87010a","canonical_identity":{"paper_id":630612,"paper_uid":"f0028e3f-4fe7-4b56-ad8f-e1473f87010a","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/22166340"}